Hair Relaxer Cancer Lawsuit: See If You Qualify for Compensation
A landmark NIH-funded study found that women who frequently used chemical hair straighteners had more than twice the risk of uterine cancer. If you've been diagnosed, you may have a legal claim against the manufacturers. Federal MDL 3060 now holds an estimated 10,000 to 15,000 consolidated cases, with the final bellwether pool selected in March 2026 and the first bellwether trials now expected in 2027.
The Hair Relaxer Cancer Research
In October 2022, a large study published in the Journal of the National Cancer Institute - using data from the NIH-funded Sister Study, which followed over 33,000 women for nearly 11 years - found that women who frequently used chemical hair straightening products had a significantly elevated risk of developing uterine cancer compared to women who never used them.
The researchers found that approximately 1.64% of women who never used hair straighteners developed uterine cancer by age 70, compared to approximately 4.05% of women who used them frequently. This more than 2.5× higher risk remained statistically significant after controlling for other factors.
Products named in current hair relaxer lawsuits include brands marketed and sold by L'Oréal, Revlon's former brands, Wella/Coty, Strength of Nature, and others. The lawsuits allege that these products contain endocrine-disrupting chemicals - including parabens, phthalates, and other compounds - that manufacturers knew or should have known posed health risks and failed to adequately disclose.
Federal MDL 3060, in the Northern District of Illinois, consolidates hair relaxer personal injury lawsuits from across the country. The MDL was established in 2023 and now holds an estimated 10,000 to 15,000 cases as of April 2026. Having a coordinated MDL means cases benefit from shared discovery and legal work, which can lead to more efficient resolution.
Bellwether proceedings are moving forward: the court held Science Day in January 2026, fact discovery on the initial 32 bellwether candidates was due February 16, 2026, and the final 10 bellwether cases were selected in March 2026. Earlier target trial dates (November 2025 and February 2026) did not proceed; the first bellwether trials are now expected in 2027.
Do You Qualify? Common Eligibility Criteria
While every case is unique and requires individual attorney review, individuals who may have a viable hair relaxer claim typically meet criteria similar to the following:
✓ You May Qualify If You:
- Used chemical hair relaxers or straighteners frequently (typically 4+ times per year) for 1 or more years
- Have been diagnosed with uterine cancer (endometrial cancer)
- Have been diagnosed with ovarian cancer (in some claims)
- Have been diagnosed with uterine fibroids requiring surgery or significant medical treatment
- Used products including Dark and Lovely, Motions, ORS Olive Oil, Just for Me, or similar brands
Products Named in Litigation
Products named in current hair relaxer lawsuits include brands marketed and sold by L'Oréal, Revlon's former brands, Wella/Coty, Strength of Nature, and others. The lawsuits allege that these products contain endocrine-disrupting chemicals - including parabens, phthalates, and other compounds - that manufacturers knew or should have known posed health risks and failed to adequately disclose.
MDL 3060 Bellwether Timeline
Federal MDL 3060, in the Northern District of Illinois, consolidates hair relaxer personal injury lawsuits from across the country. The MDL was established in 2023 and now holds an estimated 10,000 to 15,000 cases as of April 2026. Bellwether proceedings are moving forward: Science Day was held in January 2026, fact discovery on the initial 32 bellwether candidates was due February 16, 2026, and the final 10 bellwether cases were selected in March 2026. Earlier target trial dates in late 2025 / early 2026 did not proceed; the first bellwether trials are now expected in 2027. Verdicts or global resolutions typically follow the first round of bellwether trials.
Why Claimants Choose UnitedClaimsBureau
UCB connects hair relaxer injury victims with experienced mass tort attorneys at no upfront cost. Here is what to expect when you work with us.
Science-Backed Claims
Hair relaxer litigation is grounded in a landmark NIH-funded study. Attorneys in our network are experienced in presenting this science effectively to build compelling claims.
MDL-Experienced Attorneys
The hair relaxer MDL is an active federal proceeding. We connect claimants with attorneys who understand how to navigate MDL proceedings and advocate effectively for individual claimants.
Contingency Representation
Attorneys in our network work on a contingency fee basis. Your path to justice should not depend on your financial situation.
Simple Process
A confidential case review is the first step. Attorneys will evaluate your use history and diagnosis, explain your options, and handle all legal work if your case qualifies.
Frequently Asked Questions
What is the connection between hair relaxers and cancer?
Which hair relaxer products are involved in the lawsuits?
Who qualifies to file a hair relaxer lawsuit?
Is there an MDL for hair relaxer cases?
What if I used multiple hair relaxer brands?
How long do I have to file a hair relaxer claim?
What compensation can claimants receive?
Do I need medical records proving I have cancer to file?
Used Hair Relaxers and Diagnosed With Cancer?
A landmark NIH-funded study found a significant link. If you've been diagnosed with uterine or ovarian cancer and used chemical hair relaxers, you may have a legal claim for compensation. Get a confidential case review today.
Start Your Case Review